D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 69 Citations 15,140 292 World Ranking 2767 National Ranking 238

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Enzyme
  • Chromatography

His primary areas of investigation include Chromatography, Designer drug, Metabolite, Gas chromatography–mass spectrometry and Forensic toxicology. His research on Chromatography frequently links to adjacent areas such as Drug. His studies deal with areas such as Amphetamine, Microsome, Glucuronidation and Hydroxylation as well as Designer drug.

His Metabolite research includes themes of Glycine, Phenylacetones and Metabolic pathway. The various areas that Hans H. Maurer examines in his Gas chromatography–mass spectrometry study include Deconvolution, Benzylpiperazine, Urine, Derivatization and Solid phase extraction. Hans H. Maurer combines subjects such as Artificial intelligence and Pattern recognition with his study of Forensic toxicology.

His most cited work include:

  • Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry (219 citations)
  • Current Role of Liquid Chromatography-Mass Spectrometry in Clinical and Forensic Toxicology (213 citations)
  • Liquid chromatography-mass spectrometry in forensic and clinical toxicology. (183 citations)

What are the main themes of his work throughout his whole career to date?

Hans H. Maurer mostly deals with Chromatography, Gas chromatography–mass spectrometry, Designer drug, Metabolite and Urine. His research on Chromatography often connects related topics like Drug. Hans H. Maurer interconnects Solid phase extraction, Derivatization and Piperazine in the investigation of issues within Gas chromatography–mass spectrometry.

Hans H. Maurer has researched Designer drug in several fields, including Sulfation, Glucuronidation, Metabolism and Hydroxylation. His Metabolite study integrates concerns from other disciplines, such as High-performance liquid chromatography and Stereochemistry. His research integrates issues of Amphetamine and Acid hydrolysis in his study of Urine.

He most often published in these fields:

  • Chromatography (56.99%)
  • Gas chromatography–mass spectrometry (28.76%)
  • Designer drug (27.96%)

What were the highlights of his more recent work (between 2015-2021)?

  • Pharmacology (22.85%)
  • Chromatography (56.99%)
  • Forensic toxicology (14.52%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Pharmacology, Chromatography, Forensic toxicology, Mass spectrometry and Glucuronidation. His work investigates the relationship between Pharmacology and topics such as Metabolite that intersect with problems in Designer drug. Chromatography is frequently linked to Urine in his study.

Hans H. Maurer has included themes like Drugs of abuse and Drug in his Forensic toxicology study. His studies in Mass spectrometry integrate themes in fields like Gas chromatography and Extraction. Hans H. Maurer works mostly in the field of Glucuronidation, limiting it down to topics relating to Hydroxylation and, in certain cases, Sulfation, as a part of the same area of interest.

Between 2015 and 2021, his most popular works were:

  • High-resolution mass spectrometry in toxicology: current status and future perspectives (56 citations)
  • Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - Where do we stand today? (52 citations)
  • Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples. (42 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Internal medicine
  • Pharmacology

His scientific interests lie mostly in Pharmacology, Biochemistry, Forensic toxicology, Metabolite and Tandem mass spectrometry. His work on Pharmacokinetics is typically connected to Reuptake inhibitor as part of general Pharmacology study, connecting several disciplines of science. His study in Forensic toxicology is interdisciplinary in nature, drawing from both Drugs of abuse, Drug and Distribution.

The concepts of his Metabolite study are interwoven with issues in Chromatography, Monooxygenase and Designer drug. His study in Mass spectrometry and Liquid chromatography–mass spectrometry is done as part of Chromatography. His Hydroxylation course of study focuses on Gas chromatography–mass spectrometry and Enzyme.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry

Markus R. Meyer;Jens Wilhelm;Jens Wilhelm;Frank T. Peters;Hans H. Maurer.
Analytical and Bioanalytical Chemistry (2010)

332 Citations

Current Role of Liquid Chromatography-Mass Spectrometry in Clinical and Forensic Toxicology

Hans H. Maurer.
Analytical and Bioanalytical Chemistry (2007)

322 Citations

Liquid chromatography-mass spectrometry in forensic and clinical toxicology.

Hans H. Maurer.
Journal of Chromatography B: Biomedical Sciences and Applications (1998)

274 Citations

Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives.

Thomas Kraemer;Hans H Maurer.
Therapeutic Drug Monitoring (2002)

267 Citations

Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy').

Hans H Maurer;Joerg Bickeboeller-Friedrich;Thomas Kraemer;Frank T Peters.
Toxicology Letters (2000)

265 Citations

Systematic toxicological analysis of drugs and their metabolites by gas chromatography—mass spectrometry

Hans H. Maurer.
Journal of Chromatography B: Biomedical Sciences and Applications (1992)

261 Citations

Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS.

Markus R. Meyer;Peng Du;Frank Schuster;Hans H. Maurer.
Journal of Mass Spectrometry (2010)

239 Citations

Determination of amphetamine, methamphetamine and amphetamine-derived designer drugs or medicaments in blood and urine

Thomas Kraemer;Hans H Maurer.
Journal of Chromatography B: Biomedical Sciences and Applications (1998)

236 Citations

Bioanalytical method validation and its implications for forensic and clinical toxicology – A review

Frank T. Peters;Hans H. Maurer.
Accreditation and Quality Assurance (2002)

228 Citations

Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology.

Hans H. Maurer.
Clinical Biochemistry (2005)

227 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hans H. Maurer

Marilyn A. Huestis

Marilyn A. Huestis

National Institute on Drug Abuse

Publications: 46

Félix Carvalho

Félix Carvalho

University of Porto

Publications: 31

Maria de Lourdes Bastos

Maria de Lourdes Bastos

University of Porto

Publications: 27

Simona Pichini

Simona Pichini

Istituto Superiore di Sanità

Publications: 25

Rafael de la Torre

Rafael de la Torre

Pompeu Fabra University

Publications: 25

Michael H. Baumann

Michael H. Baumann

National Institute on Drug Abuse

Publications: 23

Alexander L.N. van Nuijs

Alexander L.N. van Nuijs

University of Antwerp

Publications: 22

Serge Rudaz

Serge Rudaz

University of Geneva

Publications: 21

Mario Thevis

Mario Thevis

German Sport University Cologne

Publications: 21

Damià Barceló

Damià Barceló

Institute of Environmental Assessment and Water Research

Publications: 21

Adrian Covaci

Adrian Covaci

University of Antwerp

Publications: 21

Michael Böhm

Michael Böhm

Saarland University

Publications: 19

Sara Castiglioni

Sara Castiglioni

Mario Negri Institute for Pharmacological Research

Publications: 18

Félix Hernández

Félix Hernández

Jaume I University

Publications: 18

Willy E. Lambert

Willy E. Lambert

Ghent University

Publications: 17

Paul I. Dargan

Paul I. Dargan

Guy's and St Thomas' NHS Foundation Trust

Publications: 17

Trending Scientists

Kaleem Siddiqi

Kaleem Siddiqi

McGill University

John Bound

John Bound

University of Michigan–Ann Arbor

Robert J. Glass

Robert J. Glass

Sandia National Laboratories

Jean Galy

Jean Galy

University of Bordeaux

Kwang-Deog Jung

Kwang-Deog Jung

Korea Institute of Science and Technology

Xiaolin Wei

Xiaolin Wei

Xiangtan University

Jeffrey A. McNeely

Jeffrey A. McNeely

Society for Conservation Biology Asia Section

Byron Kemper

Byron Kemper

University of Illinois at Urbana-Champaign

Matthew I. Leybourne

Matthew I. Leybourne

Queen's University

Oscar M. Lovera

Oscar M. Lovera

University of California, Los Angeles

Greg Yarwood

Greg Yarwood

Business International Corporation

Josefina Cano

Josefina Cano

University of Seville

Michael P. Kilgard

Michael P. Kilgard

The University of Texas at Dallas

Stuart L. Goldstein

Stuart L. Goldstein

Cincinnati Children's Hospital Medical Center

Fred Epstein

Fred Epstein

Mount Sinai Beth Israel

Jorge Melendez

Jorge Melendez

Universidade de São Paulo

Something went wrong. Please try again later.